CPC Main Group
C07K 16/00 Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
14 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C07K 16/02 from eggs
- C07K 16/04 from milk
- C07K 16/06 from serum
- C07K 16/08 against material from viruses
- C07K 16/12 against material from bacteria
- C07K 16/14 against material from fungi, algea or lichens
- C07K 16/16 against material from plants
- C07K 16/18 against material from animals or humans
- C07K 16/38 against protease inhibitors of peptide structure
- C07K 16/40 against enzymes
- C07K 16/42 against immunoglobulins
- C07K 16/44 against material not provided for elsewhere
- C07K 16/46 Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin C07K19/00)
Top Applicants
Top 10 applicants by patent filingsfor class C07, 2013–2023, worldwide · Source: EPO PATSTAT
- ROCHE CH 12,683
- NOVARTIS CH 10,775
- CHINESE ACADEMY OF SCIENCES 10,619
- BASF (BADISCHE ANILIN & SODA FABRIK) DE 9,511
- REGENERON PHARMACEUTICALS US 8,426
- BRISTOL-MYERS SQUIBB COMPANY US 7,979
- LG CHEM KR 7,978
- HARVARD UNIVERSITY US 7,706
- UNIVERSITY OF CALIFORNIA US 7,455
- SINOPEC (CHINA PETROCHEMICAL CORPORATION) 7,219